Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep589 | Diabetes therapy | ECE2017

Dapagliflozin induced vulvovaginitis in an atopic patient with type 2 diabetes mellitus

Nasiroglu Imga Narin , Catak Merve , Berker Dilek

Introduction: Dapagliflozin is sodium-glucose co-transporter receptor 2 (SGLT2) inhibitor that is recently discovered an oral antidiabetic (OAD) agent that improves glycemic control by increasing the renal excretion of glucose. Vulvovaginal candidiasis (VVC) is the infection of the vaginal vestibuler area. We present a case of VVC accompanied by use of dapagliflozin.Case: A-48-year-old woman who had T2DM since 8 years was admitted to the endocrinology cl...

ea0049ep287 | Calcium & Vitamin D metabolism | ECE2017

PTH levels in vitamin D deficiency

Catak Merve , Koseoglu Derya , Baser Ozden Ozdemir , Berker Dilek

Introduction: High level of Parathormone (PTH) impair bone health by increasing the risk of fracture. The aim is to determine the threshold value of PTH elevation to accompany deficiency or failure of Vit D. This may be an important parameter in assessing bone metabolism in clinical practice.Material and method: 931 patients who were referred to the endocrinology clinic were retrospectively studied and 880 patients diagnosed with Vit D deficiency include...

ea0063p345 | Thyroid 1 | ECE2019

Should narrower TSH and free thyroid hormone levels be targeted to reduce the cardiovascular risk of euthyroid subjects?

Cetin Zeynep , Kosem Arzu , Catak Merve , Can Bulent , Baser Ozden , Turhan Turan , Berker Dilek , Guler Serdar

Aim: Thyroid hormones have many effects on the cardiovascular system. May studies have showed that apparent or subclinical hypothyroidism increase the risk of hypertension hyperlipidemia and so lead to atherosclerosis susceptibility. This risk can be reduced by treatment. But, studies on the relationship between thyroid function tests and cardiovascular risk in euthyroid subjects are contradictory. This study was designed to investigate the effect of TSH, free T3, f...

ea0049ep1317 | Thyroid (non-cancer) | ECE2017

The position of immunoglobuline G4 positive in Hashimoto’s thyroiditis

Cetin Zeynep , Can Bulent , Catak Merve , Baser Ozden Ozdemir , Berker Dilek , Guler Serdar

Aim: There are studies showing that Hashimoto’s thyroiditis (HT) progresses more rapidly, thyroid echogenicity is lower and thyroid autoantibodies are higher titer positive in immunoglobulin G4 (IGg4) positive patients.But a small number of studies that do not support this data have also been published.We planned this study to evaluate the findings of IgG4 (+) Hashimoto’s thyroiditis cases.Materials and methods: New diagnosis without treatment ...

ea0049ep1329 | Thyroid (non-cancer) | ECE2017

Succesfull treatment of hyperthyroidism with plasmapheresis

Baser Ozden Ozdemir , Koseoglu Derya , Catak Merve , Cetin Zeynep , Berker Dilek

Introduction: Hyperthyroidism is the condition that occurs due to excessive release of thyroid hormone by the thyroid gland. Anti-thyroid drugs are usually the first choice of the treatment but surgery and radioactive iodine can also be used in treatment of hyperthyroidism. Plasmapheresis is a rapid and effective treatment option in cases where immediate euthyroidism is needed to be obtained due to complications of thyrotoxicosis and major side effects of antithyroid drugs.</p...

ea0041ep377 | Clinical case reports - Thyroid/Others | ECE2016

Changing of thyroid status in an autoimmune polyglandular syndrome type 2

Onal Eda Demir , Aslan Nazli Pelin , Catak Merve , Sener Ilknur , Berker Dilek , Guler Serdar

Introduction: Autoimmune polyglandular syndrome type 2 (APS2) is the most common form of the polyglandular failure syndromes. Seventy-five percent of cases occur in women. Adrenal insufficiency is the principal manifestation occurs with autoimmune thyroid disease or type I diabetes mellitus. The incidence of autoimmune thyroid diseases in APS2 is 70%; 30% Hashimoto’s thyroiditis, 20% non toxic goiter, 20% hypertyroidism is seen. We will discuss about a patient with APS2, ...